Sleep Tech Investors

No Sleep Beverage is an investment and brand-building firm focused on the alcohol beverage industry. They specialize in developing and scaling emerging beverage startups that capture culture through transcendent drinking experiences in the United States.

Eutopia is a Paris and New York based early stage venture capital fund. We invest in consumer startups who are rethinking the way we eat, sleep, dress, exercise and feel. We empower early-stage startups to grow through investment, in-house expertise and a network of global advisors.

415 Capital Management GmbH & Co is a venture capital firm that invests in clinical through commercial stage med tech companies. The firm does not invest in biotech/pharma, healthcare services and wellness products sectors. The firm primarily invest in innovative medical device technologies addressing cardio and neurovascular disease. They typically invest in med tech, medical robotics, structural heart disease, heart failure, aortic and peripheral vascular disease, neurovascular disease/stroke, hypertension, electrophysiology, neuromodulation for chronic diseases (e.g. cardiovascular, sleep apnea), medical imaging, patient monitoring sectors. The firm prefers to invest in the companies based in Europe, North America, and Israel. The firm makes equity investments between €5 million ($5.46 million) and €15 million ($16.40 million) per company. 415 Capital Management GmbH & Co was founded in 2018 and is based in Munich, Germany.

Amgen Ventures is a venture capital arm of Amgen Inc. specializing in direct investments in early stage, seed/startup, growth capital, mid venture, later stage, and emerging companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, bone health, nephrology, metabolic disorders, neuroscience, and cardiovascular therapeutics. In oncology, it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care, including mucositis and cachexia. In nephrology, the firm focuses on renal failure and hyperparathyroidism. For inflammation, the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders, it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology, the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in Thousand Oaks, California; with additional offices in San Francisco, California; Seattle, Washington; and Cambridge, Massachusetts.

Tamarak Capital is a venture-focused, multi-family office headquartered in Springville, Utah. Established in 2016, the firm has invested in over a dozen Utah companies, ranging from startups to well-established businesses. Tamarak combines its partners' experience in scaling high-growth ventures with additional personnel resources, such as marketing, accounting, and operations, to help each investment succeed. They invest in talented, curious, and teachable founders who run scalable ventures and inspire those around them. ( In September 2022, Tamarak expanded to a multi-family office with external funding from Sam and Kacie Malouf, founders of the home furnishings and sleep technology company Malouf. This partnership aims to fuel the next generation of Utah entrepreneurs and establish Tamarak as the premier seed investor in the state. Tamarak's portfolio includes companies across various industries, such as B2B software, consumer software, home technology, industrial, fintech, automotive, and real estate. The firm offers a comprehensive service stack, including business support, marketing expertise, and professional consulting, to assist portfolio companies in achieving meaningful growth. Tamarak is also committed to philanthropy, partnering with The Malouf Foundation to combat child sexual exploitation.

Topspin Consumer Partners is a private equity firm based in Mamaroneck, New York, specializing in investing in established, profitable, and fast-growing middle-market consumer businesses. Founded in 2000, the firm focuses on sectors such as health & wellness, personal care & beauty, food & beverage, household goods, pet, and children's products. Topspin partners with founder-owners and management teams to drive growth through strategic guidance, operational expertise, and access to capital. Their investment approach emphasizes long-term value creation by enhancing distribution channels, expanding product lines, and implementing effective marketing strategies. The firm has a history of successful investments, including companies like Bear Down Brands, Coop Sleep Goods, Japonesque, MISSION, Recom, SportPet, Three Dog Bakery, and JD Beauty. Topspin's team comprises professionals with extensive experience in consumer investing, sharing a common investment philosophy and complementary industry skills. Notable team members include Managing Partner Leigh Randall, Partner Stephen Parks, and Operating Partners Josh Shaw and Venus Williams. The firm has raised significant capital, with its second fund, Topspin Consumer Partners II, closing at a hard cap of $205 million in June 2021. This fund continues Topspin's strategy of partnering with growth-oriented consumer companies, investing between $15 million to $35 million in lower middle-market businesses. Topspin's portfolio showcases a diverse range of consumer brands, reflecting its commitment to building strong, innovative companies in the consumer sector.

Welltech Ventures is a venture capital firm specializing in seed, series A, startups & early-stage investments. It prefers to invest in wellness centered companies focusing on health care, physical wellness, longevity, wellness sustainability, prevention, and personalized medicine, remote and self-care, physical activity, nutrition, mental health and sleep, social wellness, and disruptive technology. It prefers to invest in Israel. Welltech Ventures was founded in 2021 and is based in Tel Aviv, Israel.

One Better Ventures nurtures and develops consumer brands that have a positive impact on the world. We advise, invest in, and incubate mission-driven ventures with breakthrough sustainable business models. Our track record includes building businesses like Burt’s Bees and Seventh Generation, and leading them to successful exits. Now we are working with innovative ventures like Leesa Sleep and Filter Easy as aligned, principled, and patient investors and operating partners. We run One Better Ventures with a deep commitment to service and corporate citizenship in our community, and we donate 10% of our profits to charity and another 10% to an employee bonus pool. Do well. Do good. Do One Better.

Personal Health Solutions Capital is a venture capital firm specializing in investments in early to mid stage businesses. The firm typically invests in science based technology enabled solutions in the consumer health and well-being sector including self-care health; prevention and management of chronic disease; lifestyle solutions; environmental solutions; and enhanced appearance, including health and beauty. Within self-care health it focuses on co-created systems, information and decision support, and integrated care approaches. Within prevention and management of chronic disease it focuses on activity, nutrition, sleep, stress, monitoring, behavior change, metabolic health, and functional foods. Within lifestyle solutions it focuses on monitoring, care giving, reproductive health, cognitive fitness, balance, and mental sustainment. Within environmental solutions it focuses on sanitation, air, water, and food. Within enhanced appearance it focuses on targeted approaches, non invasive alternatives, integrated systems, aesthetics, professional to home use and disease prevention. The firm typically invests in companies based in Europe and North America. Personal Health Solutions Capital is based in Amsterdam, Netherlands.